New Research Offers Hope for Children with Peanut Allergies
A groundbreaking NIH-funded study reveals that children with peanut allergies who can already tolerate small amounts can significantly increase their threshold through a home-based peanut therapy.
The findings could change how peanut allergies are managed for approximately 800,000 U.S. children, providing an alternative to strict avoidance.
New Peanut Allergy Treatment Shows Encouraging Results
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) have found that a gradual, home-based peanut exposure method enables peanut-allergic children to safely tolerate up to three tablespoons of peanut butter. Published in NEJM Evidence, the study provides a potential treatment pathway for children with high-threshold peanut allergies.
A Need for New Approaches
Current FDA-approved treatments primarily target children with low-threshold peanut allergies—those who react to even trace amounts of peanuts. These therapies aim to reduce the severity of accidental exposures rather than build tolerance.
However, this approach does not address children who can tolerate small amounts of peanut but still face restrictions.
How the Study Was Conducted
The study included 73 children aged 4 to 14 years. Researchers divided them into two groups:
- Peanut-Ingestion Group: Children consumed gradually increasing amounts of peanut butter over 18 months.
- Avoidance Group: Children continued avoiding peanuts as per standard care.
Doses increased under medical supervision, ensuring safety. None of the children in the ingestion group required epinephrine for severe allergic reactions during home dosing.
Significant Improvement in Peanut Tolerance
At the end of the trial, children underwent a supervised oral food challenge to assess their peanut tolerance.
Study Results Summary
| Study Group | Initial Peanut Tolerance | Final Peanut Tolerance (9g) | Achieved Sustained Unresponsiveness |
|---|---|---|---|
| Peanut-Ingestion | At least ½ peanut | 100% (32/32) | 68.4% (26/38) |
| Avoidance Group | At least ½ peanut | 10% (3/30) | 8.6% (3/35) |
- 100% of children in the peanut-ingestion group could tolerate 9 grams of peanut protein (three tablespoons of peanut butter) at the end of the trial.
- 68.4% of treated children achieved sustained unresponsiveness, meaning they maintained tolerance even after stopping peanut consumption for eight weeks.
A Safe and Effective Treatment
This method provides a practical, cost-effective way to improve peanut tolerance. The study reported minimal side effects, with only one child requiring epinephrine during supervised dose increases.
Future Implications
These findings suggest that controlled peanut exposure could offer a viable option for many children with peanut allergies. Researchers plan to explore whether similar strategies could work for other food allergies.
What This Means for Families
For parents of peanut-allergic children, this research provides new hope. While further studies are needed, these results indicate that careful peanut introduction under medical supervision could reduce the burden of peanut allergies.
Learn More
For additional details, visit the CAFETERIA study on ClinicalTrials.gov (Study ID: NCT03907397).
Sources: National Institutes of Health.
